Repligen | RGEN - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Agilent USD 37.86B 3.64B 2025-12
Align Technology USD 11.2B 2.13B 2025-12
Bio Techne USD 9.16B 502M 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Bruker USD 7.16B 2.23B 2025-12
Charles River Laboratories USD 10.02B 2.71B 2025-12
Danaher USD 161.7B 29.34B 2025-12
Dentsply International USD 2.28B 251M 2025-12
General Electric Aerospace USD 324.91B 5.91B 2025-12
Henry Schein USD 8.96B 951M 2025-12
Illumina USD 20.62B 6.53B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Mettler Toledo International USD 28.48B 3.19B 2025-12
Myriad Genetics USD 575M 98M 2025-12
OraSure Technologies USD 174M 61M 2025-12
Pacific Biosciences Of California USD 565M 180M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Repligen USD 9.22B 1.7B 2025-12
Revvity USD 10.97B 1.21B 2025-12
Standard Biotools USD 492M 5M 2025-12
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
Waters USD 22.61B 5.25B 2025-12
West Pharmaceutical Services USD 19.8B 932M 2025-12